Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 280.00
Bid: 276.00
Ask: 278.00
Change: -6.00 (-2.10%)
Spread: 2.00 (0.725%)
Open: 280.00
High: 280.00
Low: 276.00
Prev. Close: 286.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 24th Feb 2022 15:54

Friday 25 February 
Evraz PLCFull Year Results
IMI PLCFull Year Results
International Consolidated Airlines Group SAFull Year Results
Jupiter Fund Management PLCFull Year Results
Pearson PLCFull Year Results
Rightmove PLCFull Year Results
Monday 28 February 
Associated British Foods PLCTrading Statement
BATM Advanced Communications LtdFull Year Results
Bunzl PLCFull Year Results
CentralNic Group PLCFull Year Results
GlobalData PLCFull Year Results
Greencoat Renewables PLCFull Year Results
Grit Real Estate Income Group LtdHalf Year Results
Kitwave Group PLCFull Year Results
Kosmos Energy LtdQ4 Results
Made Tech Group PLCHalf Year Results
RHI Magnesita NVFull Year Results
Tuesday 1 March 
abrdn PLCFull Year Results
Croda International PLCFull Year Results
Flutter Entertainment PLCFull Year Results
Hotel Chocolat Group PLCHalf Year Results
Intertek Group PLCFull Year Results
Man Group PLCFull Year Results
PCI-PAL PLCHalf Year Results
Quartix Technologies PLCFull Year Results
Reach PLCFull Year Results
Revolution Bars Group PLCHalf Year Results
Rotork PLCFull Year Results
Travis Perkins PLCFull Year Results
Uniphar PLCFull Year Results
Vitec Group PLCFull Year Results
XP Power LtdFull Year Results
Wednesday 2 March 
Polymetal International PLCFull Year Results
Just Eat Takeaway.com NVFull Year Results
Vistry Group PLCFull Year Results
Nichols PLCFull Year Results
Hotel Chocolat Group PLCHalf Year Results
Devro PLCFull Year Results
KRM22 PLCFull Year Results
Supermarket Income REIT PLCHalf Year Results
Foxtons Group PLCFull Year Results
Persimmon PLCFull Year Results
Hiscox PLCFull Year Results
musicMagpie PLCFull Year Results
Vivo Energy PLCFull Year Results
Aviva PLCFull Year Results
Thursday 3 March 
Admiral Group PLCFull Year Results
Avation PLCHalf Year Results
Coats Group PLCFull Year Results
CRH PLCFull Year Results
Darktrace PLCHalf Year Results
Dotdigital GroupFull Year Results
Elementis PLCFull Year Results
Empiric Student Property PLCFull Year Results
Entain PLCFull Year Results
Franchise Brands PLCFull Year Results
Galliford Try Holdings PLCHalf Year Results
Hansard Global PLCHalf Year Results
Hutchmed (China) LtdFull Year Results
ITV PLCFull Year Results
London Stock Exchange Group PLCFull Year Results
Meggitt PLCFull Year Results
Melrose Industries PLCFull Year Results
Mondi PLCFull Year Results
PageGroup PLCFull Year Results
Rentokil Initial PLCFull Year Results
Schroders PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Synthomer PLCFull Year Results
Taylor Wimpey PLCFull Year Results
Tritax Big Box REIT PLCFull Year Results
Tyman PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2020 15:54

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

Read more
29 May 2020 17:06

UK TRADING UPDATE SUMMARY: New Trend Lifestyle Sees Extended Turmoil

UK TRADING UPDATE SUMMARY: New Trend Lifestyle Sees Extended Turmoil

Read more
17 Apr 2020 13:19

Hutchison China Gets US FDA Fast Track Status For Surufatinib

Hutchison China Gets US FDA Fast Track Status For Surufatinib

Read more
3 Mar 2020 14:24

Hutchison China Sees Loss Widen But Lays "Foundations" In 2019

Hutchison China Sees Loss Widen But Lays "Foundations" In 2019

Read more
25 Feb 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
12 Feb 2020 17:27

FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials

By Tamara Mathias, Roxanne Liu and Manojna MaddipatlaFeb 12 (Reuters) - The fast-spreading coronavirus is starting to disrupt testing of experimental medicines in China, posing a threat to plans by global drugmakers that have invested billions of ...

Read more
10 Feb 2020 07:36

Hutchison Chi-Med shares up on updated results from 'CALYPSO'

(Sharecast News) - Hutchison China MediTech, trading as Chi-Med, announced the availability of updated results from the phase 2 'CALYPSO' study of the savolitinib and 'Imfinzi' (durvalumab) combination in a cohort of patients with metastatic papillary renal cell carcinoma (PRCC) on Monday.

Read more
23 Jan 2020 15:06

Hutchison China Prices USD110 Million American Depositary Share Offer

Hutchison China Prices USD110 Million American Depositary Share Offer

Read more
22 Jan 2020 10:44

Hutchison China Plans USD110 Million American Depositary Share Offer

Hutchison China Plans USD110 Million American Depositary Share Offer

Read more
20 Jan 2020 16:00

Hutchison Chi-Med upbeat on progress with surufatinib

(Sharecast News) - Hutchison China MediTech, trading as Chi-Med, announced on Friday that the independent data monitoring committee of the phase 3 pivotal study of surufatinib in advanced neuroendocrine tumours - pancreatic (SANET-p) has completed a pre-planned interim analysis.

Read more
20 Jan 2020 11:37

Hutchinson China Reports Early Success Of Surufatinib Phase III Study

Hutchinson China Reports Early Success Of Surufatinib Phase III Study

Read more
13 Jan 2020 09:01

Hutchison China Starts Phase II Study For Cancer Treatment In China

Hutchison China Starts Phase II Study For Cancer Treatment In China

Read more
20 Dec 2019 15:48

Hutchison Chi-Med gets priority review for 'surufatinib' in China

(Sharecast News) - Hutchison China MediTech announced on Friday that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted 'Priority Review' status to its new drug application for 'surufatinib', for the treatment of patients with advanced non-pancreatic neuroendocrine tumours.

Read more
20 Dec 2019 12:10

Hutchison China Hails "Positive Step" For Cancer Treatment In China

Hutchison China Hails "Positive Step" For Cancer Treatment In China

Read more
28 Nov 2019 14:58

Hutchison China MediTech's Cancer Treatment Joins Key China State List

Hutchison China MediTech's Cancer Treatment Joins Key China State List

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.